Cytosorbents Corporation (CTSO) Financial Statements (2024 and earlier)

Company Profile

Business Address 305 COLLEGE ROAD EAST
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,13122,14552,13871,42212,23222,369
Cash and cash equivalents14,13122,14552,13871,42212,23222,369
Receivables6,0575,6654,5235,1594,4673,943
Inventory, net of allowances, customer advances and progress billings3,6803,4624,7662,6742,114833
Inventory3,6803,4624,7662,6742,114833
Contract with customer, asset, after allowance for credit loss    2,997  
Other undisclosed current assets1,8342,4892,8722022,0881,119
Total current assets:25,70333,76064,29982,45320,90228,264
Noncurrent Assets
Operating lease, right-of-use asset12,05912,60413,4231,0291,071
Property, plant and equipment10,05610,7435,1512,1201,9251,730
Restricted cash and investments1,4841,6871,687   
Other noncurrent assets3,9594,4374,9594,3483,4852,753
Total noncurrent assets:27,55829,47225,2207,4976,4814,483
TOTAL ASSETS:53,26163,23289,51989,95027,38332,747
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,3002,5064,0032,4672,7772,042
Interest and dividends payable  10977
Employee-related liabilities154   
Accounts payable3,8021,6552,8051,8352,0391,486
Accrued liabilities 4988511,044632629480
Deferred revenue 1,3811,5171,947728172
Debt2,500   2,095667
Contract with customer, liability42
Other undisclosed current liabilities6,3655,6927,7396,9584,8933,787
Total current liabilities:14,5469,71513,69010,1539,9366,538
Noncurrent Liabilities
Long-term debt and lease obligation2,5435,00013,25158214,0289,275
Long-term debt, excluding current maturities2,5435,000  13,3869,275
Liabilities, other than long-term debt12,89713,142    
Operating lease, liability12,89713,14213,251582643
Other undisclosed noncurrent liabilities   (13,251)(582)  
Total noncurrent liabilities:15,44018,14213,25158214,0289,275
Total liabilities:29,98527,85726,94110,73523,96415,813
Equity
Equity, attributable to parent23,27535,37562,57879,2163,41816,935
Common stock544443433332
Additional paid in capital305,197287,000283,194277,533191,649186,138
Accumulated other comprehensive income (loss)5292,329526(1,734)526288
Accumulated deficit(282,505)(253,998)(221,185)(196,627)(188,789)(169,524)
Total equity:23,27535,37562,57879,2163,41816,935
TOTAL LIABILITIES AND EQUITY:53,26163,23289,51989,95027,38332,747

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues36,34934,68943,16641,00524,94922,504
Cost of revenue
(Cost of Goods and Services Sold)
(13,957)(13,956)(11,047)(11,052)(7,364)(7,489)
Gross profit:22,39220,73332,11829,95217,58615,015
Operating expenses(53,601)(52,255)(54,863)(40,323)(36,560)(30,599)
Operating loss:(31,209)(31,522)(22,745)(10,370)(18,974)(15,585)
Nonoperating income (expense)1,888(2,383)(2,550)1,406(1,384)(2,246)
Gain (loss), foreign currency transaction, before tax1,949(2,449)(2,578)2,607(350)(785)
Loss from continuing operations before income taxes:(29,321)(33,905)(25,295)(8,964)(20,358)(17,831)
Income tax benefit 8141,0937361,1271,092620
Other undisclosed income from continuing operations      
Loss from continuing operations:(28,507)(32,813)(24,559)(7,837)(19,266)(17,211)
Loss before gain (loss) on sale of properties:(24,559)(7,837)(19,266)(17,211)
Net loss available to common stockholders, diluted:(28,507)(32,813)(24,559)(7,837)(19,266)(17,211)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(28,507)(32,813)(24,559)(7,837)(19,266)(17,211)
Comprehensive loss:(28,507)(32,813)(24,559)(7,837)(19,266)(17,211)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,800)1,8042,260(2,260)238649
Comprehensive loss, net of tax, attributable to parent:(30,307)(31,009)(22,299)(10,097)(19,028)(16,562)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: